PARP inhibitors for metastatic breast cancer

Platelet activation and blood coagulation in atherothrombosis

Using aspirin for atherothrombosis in diabetic patients

Why we need more well trained biobankers

Interindividual variability in the extent and duration of platelet thromboxane inhibition by low-dose aspirin

Aspirin and diabetes: The benefits and risks

Clinical trials of low-dose aspirin combined with low-dose rivaroxaban

Using gastroprotectants to combat aspirin-related gastrointestinal bleeding

Reducing the risk of GI bleeding with antithrombotic drugs

The 'one dose fits all' approach to aspirin

The importance of clinical trials on dosing

Impact of research on platelet activation and inhibition